357 related articles for article (PubMed ID: 19070506)
1. Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.
Mounier N; Katlama C; Costagliola D; Chichmanian RM; Spano JP
Crit Rev Oncol Hematol; 2009 Oct; 72(1):10-20. PubMed ID: 19070506
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related malignancies: state of the art and therapeutic challenges.
Spano JP; Costagliola D; Katlama C; Mounier N; Oksenhendler E; Khayat D
J Clin Oncol; 2008 Oct; 26(29):4834-42. PubMed ID: 18591544
[TBL] [Abstract][Full Text] [Related]
3. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
Klibanov OM; Clark-Vetri R
Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
5. AIDS-related malignancies: revisited.
Cáceres W; Cruz-Amy M; Díaz-Meléndez V
P R Health Sci J; 2010 Mar; 29(1):70-5. PubMed ID: 20222338
[TBL] [Abstract][Full Text] [Related]
6. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis against adverse effects of chemotherapy for HIV positive patients].
Bentata M
Bull Cancer; 2003 May; 90(5):427-34. PubMed ID: 12850766
[TBL] [Abstract][Full Text] [Related]
8. [HIV-related malignancies: state of art].
Gobert A; Mounier N; Lavole A; Poizot-Martin I; Spano JP
Bull Cancer; 2014 Nov; 101(11):1020-9. PubMed ID: 25418594
[TBL] [Abstract][Full Text] [Related]
9. Antitumour effects of antiretroviral therapy.
Monini P; Sgadari C; Toschi E; Barillari G; Ensoli B
Nat Rev Cancer; 2004 Nov; 4(11):861-75. PubMed ID: 15516959
[TBL] [Abstract][Full Text] [Related]
10. The oncology impact of highly active antiretroviral therapy.
Schlichemeyer R; Chambers C; Gill MJ
J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
12. Malignancies in HIV: the Indian scenario.
Dhir AA; Sawant SP
Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
[TBL] [Abstract][Full Text] [Related]
13. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
Taiwo B; Hicks C; Eron J
J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
[TBL] [Abstract][Full Text] [Related]
14. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
Silverberg MJ; Abrams DI
Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral and statin drug-drug interactions.
Ray GM
Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
[TBL] [Abstract][Full Text] [Related]
16. The role of cytochrome P450 in antiretroviral drug interactions.
Walubo A
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):583-98. PubMed ID: 17696808
[TBL] [Abstract][Full Text] [Related]
17. Non-AIDS defining cancers.
Layton JL; Castillo JJ
Med Health R I; 2010 Oct; 93(10):296-8. PubMed ID: 21284267
[No Abstract] [Full Text] [Related]
18. Hematologic complications of HIV infection.
Sloand E
AIDS Rev; 2005; 7(4):187-96. PubMed ID: 16425959
[TBL] [Abstract][Full Text] [Related]
19. [Clinically significant drug interactions in HIV-infected patients].
Weisser M; Battegay M
Ther Umsch; 1998 May; 55(5):310-22. PubMed ID: 9643129
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.
Andrade RA; Evans RT; Hamill RJ; Zerai T; Giordano TP
Ann Pharmacother; 2009 May; 43(5):908-13. PubMed ID: 19401476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
